BNP Paribas Financial Markets
ELOS

BNP Paribas Financial Markets’s Syneron Medical Ltd ELOS Stock Holding History

BNP Paribas Financial Markets’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-962
Closed – – 4562
2018
Q1 		$0 Hold
962
– – ﹤0.01% 4449
2017
Q4 		$0 Buy
+962
New – ﹤0.01% 4403
2017
Q3 		– Sell
-962
Closed -$10.5K – 4381
2017
Q2 		$10.5K Hold
962
– – ﹤0.01% 3931
2017
Q1 		$10.1K Hold
962
– – ﹤0.01% 3172
2016
Q4 		$8.08K Hold
962
– – ﹤0.01% 3548
2016
Q3 		$6.89K Hold
962
– – ﹤0.01% 3316
2016
Q2 		$7.4K Hold
962
– – ﹤0.01% 3069
2016
Q1 		$7.03K Sell
962
-962
-50% -$6.89K ﹤0.01% 2252
2015
Q4 		$14.8K Buy
1,924
+962
+100% +$7.34K ﹤0.01% 3351
2015
Q3 		$6.88K Buy
962
+85
+10% +$817 ﹤0.01% 3462
2015
Q2 		$9.31K Buy
877
+21
+2% +$246 ﹤0.01% 3352
2015
Q1 		$10.6K Buy
856
+452
+112% +$5K ﹤0.01% 2714
2014
Q4 		$3.77K Buy
+404
New +$3.9K ﹤0.01% 1832

BNP Paribas Financial Markets's ELOS Position: Q2 2018 in Review

BNP Paribas Financial Markets sold out of Syneron Medical Ltd (ELOS) in Q2 2018, closing a stake of 962 shares.

BNP Paribas Financial Markets first reported a position in ELOS in Q4 2014 and held it in 13 quarters. The position peaked at $14.8K in Q4 2015. 0 funds tracked by Wall St. Rank hold ELOS as of Q2 2018.

  • BNP Paribas Financial Markets reported no remaining Syneron Medical Ltd position as of Q2 2018 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 962 Syneron Medical Ltd shares in Q2 2018.
  • BNP Paribas Financial Markets first reported a position in Syneron Medical Ltd in Q4 2014 and held it in 13 quarters.
  • BNP Paribas Financial Markets's Syneron Medical Ltd position peaked at $14.8K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2018.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2018, filed 25 Jul 2018.